Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Latinos and Hispanics Prone to Kidney Disease Gene Variant

By LabMedica International staff writers
Posted on 21 Jan 2019
Risk variants in the apolipoprotein A-I (APOL1) gene on chromosome 22, which were first discovered in African Americans, confer a substantially increased risk of kidney disease, early-onset hypertension, and cardiovascular disease, although disease risk is modified by other genetic factors and by environmental factors.

However, other populations who also share recent ancestry from Africa, such as Hispanic populations, may be at greater risk than expected for APOL1-driven disease. More...
These persons may not undergo testing; however, they may still be at high risk because of the presence of APOL1 risk variants. According to the National Kidney Association, about 10% of the world's population suffers from kidney disease.

Scientists at the Icahn School of Medicine at Mount Sinai (New York, NY, USA) and their colleagues used linked genetic and demographic data from 111 populations in two large studies, the Population Architecture using Genomics and Epidemiology Study and the Consortium on Asthma among African-ancestry Populations in the Americas, to determine the global frequencies of APOL1 risk variants. They inferred risk-allele status using the two G1 alleles (rs60910145 and rs73885319) and the proxy single-nucleotide polymorphism commonly typed for G2 (rs12106505).

The investigators found elevated frequencies of the APOL1 haplotype in African-American, sub-Saharan African, and Western African populations (11% to 32%). However, they also found other populations with elevated frequencies, including Jamaican, Barbadian, Grenadian, and Brazilian from Salvador (>10% to 22%); Trinidadian, Panamanian, Honduran, Haitian, Garifunan, and Palenque (>5% to 10%); and Guyanese, Dominican, Peruvian, Belizean, and Native American (1% to 5%). These findings show that the risk alleles are present in populations of persons who are not typically screened, which may result in the under diagnosis and under treatment of kidney disease and related coexisting conditions.

Girish Nadkarni, MD, MPH, an Assistant Professor of Medicine and study first author, said, “This finding is crucial in early detection of at-risk individuals who may not be indicated for genetic screening due to self-reporting of ethnic origins, but may still be at high risk due to the presence of APOL1 risk variants. It is important to more fully understand the global distribution of these variants based on country of origin and genetic ancestry rather than self-reported race/ethnic group.” The study was published on December 27, 2018, in the journal The New England Journal of Medicine.

Related Links:
Icahn School of Medicine at Mount Sinai


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.